Episode 462: Taking Your MS to College? Understand Your Right to Accommodation with Britt Neff

The Americans with Disabilities Act ensures that people living with disabilities receive reasonable accommodations at work. That law also applies to students attending most colleges and universities. And the ADA doesn't limit itself to physical disabilities. It's often applied to invisible disabilities, as well.

This week, Britt Neff, the Access Specialist at the University of Washington School of Law, joins me to explain all the ways the accommodation process can work for college students living with MS.

We'll also tell you about PTD802, an oral remyelination therapy that's just been given a green light from the FDA to begin human clinical trials

We're sharing evidence from an important study that should make you feel more confident about getting those MMR (measles, mumps, rubella) and chickenpox vaccines.

You'll learn what researchers at the Cleveland Clinic discovered when they asked the question, "Can someone living with MS over the age of 60 discontinue their disease-modifying therapy?"

And we're sharing the details about an AI application that can predict -- with 90% accuracy -- whether someone with MS is at risk of experiencing cognitive decline over the next few years.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: Understanding "reasonable accommodation" at college  :22

FDA approves oral remyelination therapy PTD802 for Phase 1 clinical trial  1:07

Study results: MMR (measles, mumps, rubella) and chickenpox vaccines are shown to be safe for people with MS  4:52

Study results: Is it safe for someone living with MS over 60 to discontinue their DMT?   7:34

Study results: AI predicts future cognitive changes among people with MS with 90% accuracy   10:45